Empress Therapeutics

Curated by Signal

AI-powered drug discovery platform to generate drug candidates

Overview

AI-powered drug discovery platform to generate drug candidates. The company uses the Chemilogics platform integrated with AI and synthetic biology to find DNA sequences that encode the synthesis of small molecules for a broad range of diseases.

Key facts

Founded: 2022
Headquarters: Cambridge, United States
Stage: Sign up to view
Industry: Health Technology

Contact

Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Curvy Yoga
Provider of guidance to practice yoga
Health TechnologyPortland, United States
Grace Health Technology
Cloud-based administrative solutions for clinical labs
Health TechnologyDelray Beach, United States
NLTIX Edge
Provider of AI-powered healthcare solutions improving efficiency and accuracy
Health TechnologyHouston, United States

About Empress Therapeutics

What does Empress Therapeutics do?

AI-powered drug discovery platform to generate drug candidates.

Where is Empress Therapeutics headquartered?

Empress Therapeutics is headquartered in Cambridge, United States.

When was Empress Therapeutics founded?

Empress Therapeutics was founded in 2022.

Which sector is Empress Therapeutics in?

Empress Therapeutics operates in Health Technology.

Who are Empress Therapeutics's competitors?

Companies similar to Empress Therapeutics include Curvy Yoga, Grace Health Technology, and NLTIX Edge.